These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2024705)

  • 1. Influence of the site of tumor growth on the capacity of a low tumorigenic line of Friend erythroleukemia cells to differentiate.
    Gresser I; Moss J; Woodrow D; Le Bousse C; Maury C; Proietti E; Belardelli F
    Am J Pathol; 1991 May; 138(5):1125-33. PubMed ID: 2024705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth properties, differentiation capacity and oncogene expression in metastatic and nonmetastatic Friend leukemia cell variants.
    Sala A; Benedetto A; Elia G; Pulciani S; Ciotta C; Parlanti E; Santodonato L; Belardelli F
    Invasion Metastasis; 1991; 11(4):192-203. PubMed ID: 1765432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
    Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
    Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon alpha/beta treatment in mice.
    Gresser I; Carnaud C; Maury C; Sala A; Eid P; Woodrow D; Maunoury MT; Belardelli F
    J Exp Med; 1991 May; 173(5):1193-203. PubMed ID: 2022926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mouse alpha/beta-interferon of the multiplication of alpha/beta-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes.
    Yasui H; Proietti E; Vignaux F; Eid P; Gresser I
    Cancer Res; 1990 Jun; 50(12):3533-9. PubMed ID: 2140290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Employment of a [3H]thymidine-incorporation assay to distinguish the effects of different Friend erythroleukemia-inducing retroviruses on erythroid cell proliferation.
    Ruscetti SK
    J Natl Cancer Inst; 1986 Jul; 77(1):241-5. PubMed ID: 3459916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
    Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
    Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochemical characteristics of leukopoietic differentiation in murine erythroleukemic (Friend) cells.
    Fioritoni G; Bertolini L; Torlontano G; Revoltella R
    Cancer Res; 1980 Mar; 40(3):866-72. PubMed ID: 6937242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in pyridine and adenine nucleotide levels in Friend erythroleukaemia cells during growth and differentiation.
    Caldini R; Chevanne M; Magnelli L
    J Cell Physiol; 1992 Apr; 151(1):172-9. PubMed ID: 1313819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 31P-nuclear magnetic resonance analysis of interferon-induced alterations of phospholipid metabolites in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice.
    Proietti E; Carpinelli G; Di Vito M; Belardelli F; Gresser I; Podo F
    Cancer Res; 1986 Jun; 46(6):2849-57. PubMed ID: 2421886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
    EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells.
    Waga K; Nakamura Y; Maki K; Arai H; Yamagata T; Sasaki K; Kurokawa M; Hirai H; Mitani K
    Oncogene; 2003 Jan; 22(1):59-68. PubMed ID: 12527908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological changes in erythroblasts during erythropoietin-induced terminal differentiation in vitro.
    Koury ST; Koury MJ; Bondurant MC
    Exp Hematol; 1988 Oct; 16(9):758-63. PubMed ID: 3169158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cells.
    Matteucci A; Faenza I; Gilmour RS; Manzoli L; Billi AM; Peruzzi D; Bavelloni A; Rhee SG; Cocco L
    Cancer Res; 1998 Nov; 58(22):5057-60. PubMed ID: 9823310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation.
    Kirsch IR; Bertness V; Silver J; Hollis GF
    J Cell Biochem; 1986; 32(1):11-21. PubMed ID: 3464612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of interferon alpha in the resistance of allogeneic C57B1/6 mice to the multiplication of Friend erythroleukemia cells in the liver.
    Gresser I; Maury C; Bandu MT; Belardelli F
    Int J Cancer; 1990 Feb; 45(2):364-71. PubMed ID: 2406205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viruses and annulate lamellae in Friend erythroleukemia cells.
    Walter RJ; Tandler B
    J Submicrosc Cytol Pathol; 1989 Jan; 21(1):93-101. PubMed ID: 2702614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A radiosensitive T-lymphocyte associated with resistance of DBA/2 mice harboring Friend leukemia virus-dormant infections to transplantable Friend leukemia virus-erythroleukemia cells.
    DiCicco LM; Truitt GA; Wheelock EF
    Cancer Res; 1986 Jan; 46(1):127-32. PubMed ID: 3509990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of base analogs upon the induction of differentation in Friend erythroleukemia cells.
    Koch G; Warnecke G; Kühne J; Bilello JA
    Adv Ophthalmol; 1979; 38():222-33. PubMed ID: 93406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.